Drug Profile
BW 9798
Latest Information Update: 24 Aug 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Anti-ischaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 24 Aug 1998 No-Development-Reported for Coronary artery restenosis in Germany (Unknown route)
- 19 Sep 1995 Preclinical development for Atherosclerosis in Germany (Unknown route)
- 13 Sep 1995 New profile